Bioluminescent aptamer-based sandwich-type assay of anti-myelin basic protein autoantibodies associated with multiple sclerosis.

Autor: Krasitskaya VV; Institute of Biophysics SB RAS, Federal Research Center 'Krasnoyarsk Science Center SB RAS', Krasnoyarsk, 660036, Russia. Electronic address: vasilisa.krasitskaya@gmail.com., Chaukina VV; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, 630090, Russia., Abroskina MV; State Medical University named after V.F. Voino-Yasenetsky, Krasnoyarsk, 660022, Russia., Vorobyeva MA; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, 630090, Russia., Ilminskaya AA; State Medical University named after V.F. Voino-Yasenetsky, Krasnoyarsk, 660022, Russia., Kabilov MR; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, 630090, Russia., Prokopenko SV; State Medical University named after V.F. Voino-Yasenetsky, Krasnoyarsk, 660022, Russia., Nevinsky GA; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, 630090, Russia., Venyaminova AG; Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, 630090, Russia., Frank LA; Institute of Biophysics SB RAS, Federal Research Center 'Krasnoyarsk Science Center SB RAS', Krasnoyarsk, 660036, Russia.
Jazyk: angličtina
Zdroj: Analytica chimica acta [Anal Chim Acta] 2019 Aug 08; Vol. 1064, pp. 112-118. Date of Electronic Publication: 2019 Mar 12.
DOI: 10.1016/j.aca.2019.03.015
Abstrakt: Bioluminescent solid-phase sandwich-type microassay was developed to detect multiple sclerosis (MS)-associated autoantibodies in human sera. The assay is based on two different 2'-F-Py RNA aptamers against the target autoantibodies as biospecific elements, and Ca 2+ -regulated photoprotein obelin as a reporter. The paper describes elaboration of the assay and its application to 91 serum samples from patients with clinically definite MS and 86 ones from individuals healthy in terms of MS. Based on the receiver-operator curve (ROC) analysis, the chosen threshold value as clinical decision limit offers sensitivity of 63.7% and specificity of 94.2%. The area under the ROC curve (AUC) value of 0.87 shows a good difference between the groups under investigation. The likelihood ratio of 10.97 proves the diagnostic value of the assay and its potential as one of the laboratory MS-tests.
(Copyright © 2019 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: